SCHEMBL17097625

SCHEMBL17097625

CCOC(=O)[C@H]1CC[C@H](n2ncc(C(=O)N(CC(=O)c3c(O)cccc3OC)Cc3cc(F)cc(F)c3)c2C(F)(F)F)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.34
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 5/20 0.34
NR1H4 Q96RI1 1/20 0.33
LPAR1 Q92633 1/20 0.32
LPAR5 Q9H1C0 1/20 0.32
CCR2 P41597 2/20 0.32
KCNH2 Q12809 2/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CYP1A2 P05177 1/20 0.32
GAA P10253 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17097627 1.00 EGFR (0.34) EGFRKDM4EALDH1A1NR1H4LPAR1
SCHEMBL17099185 0.96 EGFR (0.36) EGFRKDM4EALDH1A1NR1H4LPAR1
SCHEMBL17099186 0.96 EGFR (0.36) EGFRKDM4EALDH1A1NR1H4LPAR1
SCHEMBL17097522 0.93 POLB (0.35) EGFRKDM4EALDH1A1NR1H4LPAR1
SCHEMBL17097524 0.93 POLB (0.35) EGFRKDM4EALDH1A1NR1H4LPAR1
SCHEMBL17097638 0.92 POLB (0.34) KDM4EALDH1A1NR1H4CCR2KCNH2
SCHEMBL17097642 0.92 POLB (0.34) KDM4EALDH1A1NR1H4CCR2KCNH2
SCHEMBL17048972 0.92 ALDH1A1 (0.34) EGFRKDM4EALDH1A1LPAR1LPAR5
SCHEMBL17048970 0.92 ALDH1A1 (0.34) EGFRKDM4EALDH1A1LPAR1LPAR5
SCHEMBL17048992 0.88 LPAR1 (0.35) EGFRKDM4EALDH1A1LPAR1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA EGFR 4069/4885KDM4E 986/4885ALDH1A1 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.